Navigation Links
Hard To Treat Diseases (HTDS.PK) To Regain Intellectual Property (IP) Ownership
Date:6/24/2009

SHENZHEN, China, June 24 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS.PK) www.htdsmedical.com - announced today that the Company is in the process of recovering intellectual property (IP) rights that could provide an enormous financial benefit to the Company.

The Company retained a USA based IP consultant to attempt to recover certain intellectual property, which the current management, preferred shareholder and its corporate advisors, verily believe was inappropriately converted by the previous management of HTDS. Current HTDS management has been informed by the IP consultant, that the process of converting 100% of the ownership rights back to HTDS is underway.

The IP rights shall provide the Company with immediate revenue producing division and access to an industry with substantial potential and high profit margins. Due to the global demand and need of the process and products of these intellectual property rights, HTDS is poised to take advantage of every situation and in short order.

Terry Yuan, CEO of HTDS, stated, "HTDS is fortunate to have talented management, consultants and advisors together with the financial resources and backing, required to enable the pursuit of this opportunity; which could produce an immediate positive financial impact for our shareholders. With HTDS' global presence, numerous locations and structured divisions, we are prepared to capitalize on the ownership rights of the recovered intellectual property rights on a global scale."

"The assertion of these ownership rights is a financial windfall to HTDS," stated Keith Roberts, financial advisor - consultant to HTDS. He added, "We discovered, through our forensic due diligence after the appointment of the new management and the backing of the preferred shareholder - majority stakeholders that the 'IP' rights are being utilized by a fully reporting OTCBB publicly traded company. It is interesting to note that their revenue model is based solely on these IP rights."

Mr.Roberts continued, "HTDS has many options with respect to the IP rights. For example we can operate a division ourselves, joint venture with an experienced third party (receive royalties), or sell these rights with beneficial terms. No matter the decision; we are coming from a position of strength that our shareholders could soon recognize. I also serve as a financial advisor - consultant to several other Pink Sheet issuers, and we have witnessed these types of activities in the past, where assets and IP simply go missing or vanish altogether without a trace of paperwork. I know that the HTDS financial backers, advisors, and preferred shareholders are in a litigation mode and will vigorously pursue relief through legal means failing quick resolution of this IP matter. Notwithstanding, HTDS management is hopeful and anticipates the process of finalizing ownership rights will be resolved rather quickly and deciding on the direction of the division shortly thereafter."

The management acknowledges the cooperation and assistance of Mr.Colm King.

In other company news, the company recently retained Mina Mar Group to assist in completing and filing the "Adequate Disclosure" documents with Pink Sheets in order to comply with Pink Sheets ranking system. The company is aiming to achieve a "Current Insurer Status" ranking, being an upgrade (the highest level at it's tier) from the current "Yield Limited Information which HTDS is currently ranked at. HTDS has also retained a USA based securities qualified barrister to review these filings and to have the barrister express a legal opinion on these filings. Once shortly completed the company will file the legal opinion with Pink Sheets as well which should suffice in the company obtaining the "Current Insurer Status" ranking. Near future plans include completing a financial audit and becoming an SEC reporting issuer which are one of the first steps towards up listing to the OTCBB. The company advisors and its management are of the opinion that HTDS share values are grossly undervalued. The management remains optimistic that the aforementioned transparency, compliance, audit and the up listing plans will all transform into a higher valuation and mutually benefit both the company and all shareholders of HTDS.

The company will provide further details as they become available.

Safe Harbor Statement:

Statements contained herein that are not historical fact may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those projected or suggested in any forward-looking statements made by HTDS. These factors include, but are not limited to: (i) the ability of HTDS to successfully continue to raise financing, (ii) the ability of HTDS to repay its existing indebtedness, and (iii) the ability of HTDS to successfully estimate opportunities in certain markets. HTDS does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: For any corporate matters, please contact corporate@htdsmedical.com.

CONTACT: For any corporate matters, please contact corporate@htdsmedical.com


'/>"/>
SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. New treatment effective in counteracting cocaine-induced symptoms
3. New treatment boosts muscle function in myasthenia gravis
4. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
5. Free distribution of insecticide-treated mosquito nets can save lives
6. Kenyan malaria success strengthens call for free insecticide-treated nets for all
7. Broad-based group of physicians calls for improvement in stroke treatment
8. Cranberry Could Juice Up Ovarian Cancer Treatment
9. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
10. Non-medicinal treatment touted for pre-schoolers with ADHD
11. Nonmedicinal treatment touted for preschoolers with ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
(Date:6/24/2016)... ... , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event ... that have been wounded in battle and their families. Venture Construction Group is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
Breaking Medicine Technology: